Table 2.
Overall analytical performances for saliva compared to nasopharyngeal specimens and for symptomatic and asymptomatic patients
Symptomatic and asymptomatic patients | Symptomatic patients | Asymptomatic patients | |
---|---|---|---|
Sensitivity (IC95%) | 87.8 (83.3–92.3) | 89.4 (84.9–93.9) | 79.2 (62.9–95.4) |
Specificity (IC95%) | 97.1 (96.1–98.1) | 96.2 (94.5–97.9) | 98.0 (96.8–99.2) |
PPV (IC95%) | 92.3 (88.6–96) | 94.7 (91.3–98.1) | 76.0 (59.3–92.7) |
NPV (IC95%) | 97.8 (96.9–98.7) | 96.4 (94.7–98.1) | 99.2 (98.4–100.0) |
Kappa (IC95%) | 0.84 (0.80–0.88) | 0.86 (0.82–0.90) | 0.71 (0.57–0.85) |
NP nasopharyngeal; PPV positive predictive value; NPV negative predictive value